Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

NCT03301857 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT03301857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
November 13, 2017
Completion date
July 27, 2023
Enrollment
85 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell tumor of bone